CLDX
Celldex Therapeutics Inc
NASDAQ: CLDX · HEALTHCARE · BIOTECHNOLOGY
$32.14
-3.28% today
Updated 2026-04-29
Market cap
$2.52B
P/E ratio
—
P/S ratio
1,632.24x
EPS (TTM)
$-3.90
Dividend yield
—
52W range
$18 – $36
Volume
1.1M
Celldex Therapeutics Inc (CLDX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |